Drug recall · December 25, 2019
Memantine Hydrochloride Extended-release Capsules recall
Why: Failed Dissolution Specifications: High out of specification result observed at stability studies.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Memantine Hydrochloride Extended-release Capsules, 28mg, packaged in a) 90-count bottles (NDC 68180-249-09 and b) 500-count bottles (NDC 68180-249-02); Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202; Manufactured by: Lupin Limited, Pithampur (M.P.)-454 775, INDIA
- Lots / codes
Lot #: H901787, H901788, Exp March 2021
- Quantity
- 3,726 bottles
- Company
- Lupin Pharmaceuticals Inc., Baltimore, MD
- Distribution
- Nationwide in the USA
- Initiated
- December 10, 2019 · Voluntary: Firm initiated
- Classified
- December 23, 2019
- Reported
- December 25, 2019
- Ended
- April 29, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Memantine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.